表皮介质可塑性,屏障功能障碍和先天免疫路径之间的相互作用塑造了过敏呼吸道疾病的起源
1School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI, USA.
Expert review of respiratory medicine
|January 2, 2025
概括
在过敏性喘中,空气过敏原和病毒感染激活模式识别受体 (PRR),破坏呼吸道上皮质屏障功能. 了解这些机制为恢复屏障完整性和减少过敏炎症提供了新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 细胞生物学 细胞生物学
背景情况:
- 过敏性喘 (AA) 涉及遗传倾向的个体对空气过敏原和RNA病毒做出反应.
- 这些暴露会影响下呼吸道哨兵细胞,改变表皮屏障的功能.
- 激活的模式识别受体 (PRRs) 启动损伤修复通路,导致上皮介质可塑性 (EMP),屏障破坏和敏感化.
研究的目的:
- 阐明呼吸道上皮细胞内天生的免疫激活有助于过敏喘的机制.
- 确定新的治疗点,以恢复表皮屏障功能,减少气道重塑.
主要方法:
- 在支气管支气管结节中的哨兵上皮细胞特征的审查.
- 对空气过敏原对表皮PRR和紧接点 (TJs) 的影响的分析.
- 研究TGF-β信号传递,ICL2激活,RSV诱导的杯状细胞增生以及ER压力代谢合.
主要成果:
- 由空气过敏原或病毒产生的先天免疫激活会破坏支气管支气管交叉路口屏障的功能.
- 这种干扰促进慢性炎症和2型 (Th2) 免疫反应.
- 表皮介质可塑性 (EMP),TJ破坏,代谢重编程和细胞外基质 (ECM) 沉积是关键的病理事件.
结论:
- 了解激活的PRR如何驱动EMP,TJ干扰和代谢变化至关重要.
- 这些见解提供了生物验证的目标,以恢复屏障功能,减少敏感性,并减轻过敏性喘中的呼吸道改造.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
Allergic Reactions
27.2K
Overview
27.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236


